{"product_id":"bpc-157-tb-500-combo-stack","title":"BPC-157 + TB-500 Combo (Stack)","description":"\u003c!-- =========================================================\n  BPC-157 \/ TB-500 RESEARCH STACK — DISSOLV LABS\n  Single combined vial: 10 mg BPC-157 + 10 mg TB-500 (20 mg total)\n  Recovery category\n  Shopify product description — paste into the Code View\n  of the product description field.\n========================================================= --\u003e\n\u003ch2\u003eBPC-157 \/ TB-500 Research Stack\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 \/ TB-500 Research Stack is a combined-vial preparation that pairs two of the most extensively cited compounds within the regenerative pathway research peptide category — \u003cstrong\u003eBPC-157\u003c\/strong\u003e (a body protection compound-derived pentadecapeptide) and \u003cstrong\u003eTB-500\u003c\/strong\u003e (a synthetic Thymosin Beta-4 active fragment) — into a single lyophilized format. DISSOLV LABS supplies the stack as a \u003cstrong\u003e20 mg combined vial\u003c\/strong\u003e containing \u003cstrong\u003e10 mg BPC-157 + 10 mg TB-500\u003c\/strong\u003e, formulated for qualified laboratory research professionals conducting combination pathway research.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTotal peptide content:\u003c\/strong\u003e 20 mg (10 mg BPC-157 + 10 mg TB-500)\u003cbr\u003e\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% per component (HPLC-MS verified)\u003cbr\u003e\u003cstrong\u003eFormat:\u003c\/strong\u003e Single combined lyophilized vial\u003cbr\u003e\u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\u003c\/p\u003e\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 \/ TB-500 stack consolidates two structurally and mechanistically distinct research peptides into a single reference preparation. \u003cstrong\u003eBPC-157\u003c\/strong\u003e is a 15-amino-acid synthetic pentadecapeptide derived from a partial sequence of a larger gastric peptide (Body Protection Compound), studied in laboratory work involving connective tissue biology, angiogenesis, and gastrointestinal signaling. \u003cstrong\u003eTB-500\u003c\/strong\u003e is a synthetic peptide derived from the actin-binding region of Thymosin Beta-4, studied in laboratory work involving actin sequestration, cellular migration, and tissue remodeling.\u003c\/p\u003e\n\u003cp\u003eWithin the published literature, the two compounds are among the most frequently co-referenced research peptides in regenerative pathway studies, and combination preparations are commonly used to simplify analytical workflows in comparative pathway research. The DISSOLV LABS stack is supplied as a single combined vial to support these protocols.\u003c\/p\u003e\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 \/ TB-500 stack has been investigated as a combination preparation in preclinical research and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eComparative regenerative pathway research\u003c\/li\u003e\n\u003cli\u003eConnective tissue and tendon biology research\u003c\/li\u003e\n\u003cli\u003eAngiogenesis and vascular endothelial pathway models\u003c\/li\u003e\n\u003cli\u003eActin sequestration and cellular migration research\u003c\/li\u003e\n\u003cli\u003eTissue remodeling and extracellular matrix pathway research\u003c\/li\u003e\n\u003cli\u003eCombination peptide structure–activity profiling\u003c\/li\u003e\n\u003cli\u003eGastrointestinal and connective tissue signaling cross-pathway studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePreparation name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157 \/ TB-500 Research Stack\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eComponents\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157 (10 mg) · TB-500 (10 mg)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTotal peptide content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20 mg per vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eComponent 1\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157 — synthetic pentadecapeptide (Body Protection Compound 157, PL 14736)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eComponent 2\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTB-500 — synthetic Thymosin Beta-4 active fragment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination regenerative pathway research preparation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide families\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBody protection compound-derived synthetic peptides · Thymosin-family synthetic fragments\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTissue repair pathways, angiogenesis, connective tissue biology, actin-binding research, cellular migration, gastrointestinal signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBPC-157 (standalone), TB-500 (standalone), GHK-Cu, KPV\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEach component within the BPC-157 \/ TB-500 stack undergoes independent analytical verification before combined lyophilization, and each finished lot is documented for batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC) on each component\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS) on each component\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComponent ratio verification\u003c\/strong\u003e consistent with the 10 mg + 10 mg specification\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile combined lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSingle combined lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBPC-157 content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTB-500 content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTotal peptide content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20 mg per vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-BPCTB-020\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity per component\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is the BPC-157 \/ TB-500 Research Stack?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe BPC-157 \/ TB-500 Research Stack is a combined-vial preparation pairing two of the most extensively cited compounds within the regenerative pathway research peptide category — BPC-157 (body protection compound-derived pentadecapeptide) and TB-500 (Thymosin Beta-4 active fragment) — into a single lyophilized format. Supplied by DISSOLV LABS as an analytical reference preparation for laboratory research use only.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is inside the vial?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eEach vial contains \u003cstrong\u003e10 mg of BPC-157\u003c\/strong\u003e combined with \u003cstrong\u003e10 mg of TB-500\u003c\/strong\u003e, for a total peptide content of \u003cstrong\u003e20 mg per vial\u003c\/strong\u003e. Both components are lyophilized together as a single combined preparation.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs this one vial or two?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe stack is supplied as a \u003cstrong\u003esingle combined lyophilized vial\u003c\/strong\u003e. Both BPC-157 and TB-500 are co-lyophilized into the same vial under inert conditions, eliminating the need for two separate reconstitution workflows in combination research.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is BPC-157?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eBPC-157 is a synthetic 15-amino-acid pentadecapeptide referenced in scientific literature as a stable partial sequence derived from Body Protection Compound. It is studied within laboratory research involving connective tissue biology, angiogenesis, and gastrointestinal signaling. Also referenced as PL 14736.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat is TB-500?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eTB-500 is a synthetic peptide referenced in scientific literature as the active fragment of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid actin-binding protein. It is studied within laboratory research involving actin sequestration, cellular migration, and tissue remodeling.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhy are BPC-157 and TB-500 studied together?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eBPC-157 and TB-500 are mechanistically distinct but are frequently co-referenced in regenerative pathway literature because each compound is studied within overlapping research domains — connective tissue, angiogenesis, and tissue remodeling. Combination preparations consolidate analytical workflows in comparative pathway research and reduce variability across reconstitution protocols.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat category does the stack belong to?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe BPC-157 \/ TB-500 Research Stack is classified within the regenerative pathway research peptide category, alongside the standalone BPC-157 and TB-500 reference compounds and adjacent Recovery-category peptides including GHK-Cu and KPV.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eEach component — BPC-157 and TB-500 — is supplied at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified independently by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS) prior to combined lyophilization. Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eEach component is independently subjected to RP-HPLC purity analysis and HPLC-MS identity confirmation. The finished combined preparation is verified for component ratio (10 mg + 10 mg), residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow should the stack be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eHow is the stack reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe combined preparation is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Both peptides enter solution from the same vial, simplifying combination workflows. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs the stack research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. The BPC-157 \/ TB-500 Research Stack supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eCan I buy BPC-157 and TB-500 separately?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. DISSOLV LABS supplies BPC-157 and TB-500 as standalone reference compounds in separate 10 mg lyophilized vials. The stack is offered as a consolidated alternative for laboratories conducting combination pathway research.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWhat compounds are related to the BPC-157 \/ TB-500 stack?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe stack is commonly referenced alongside the standalone BPC-157 and TB-500 reference compounds, as well as adjacent Recovery-category peptides including GHK-Cu (copper-binding tripeptide) and KPV (α-MSH-derived tripeptide) — all of which are studied within tissue repair and regenerative pathway research domains.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting per-component purity, identity, component ratio, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003e\u003cstrong\u003eWho should handle the BPC-157 \/ TB-500 stack?\u003c\/strong\u003e\u003c\/summary\u003e\n\u003cp\u003eThe stack is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157\u003c\/strong\u003e — body protection compound-derived pentadecapeptide research peptide (standalone)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500\u003c\/strong\u003e — Thymosin Beta-4 active fragment research peptide (standalone)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e — copper-binding tripeptide research compound (glycyl-L-histidyl-L-lysine + Cu²⁺)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV\u003c\/strong\u003e — α-MSH-derived tripeptide research compound (lysine-proline-valine)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"Dissolv Labs","offers":[{"title":"Default Title","offer_id":52101944017176,"sku":null,"price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/BPC-157_TB50010mg.png?v=1779637004","url":"https:\/\/dissolv.com\/products\/bpc-157-tb-500-combo-stack","provider":"Dissolv Labs","version":"1.0","type":"link"}